Epstein-Barr virus associated graft failure following heart/lung transplantation.

2.50
Hdl Handle:
http://hdl.handle.net/10541/95806
Title:
Epstein-Barr virus associated graft failure following heart/lung transplantation.
Authors:
Egan, J J; Stewart, J P; Hasleton, Philip S; Yonan, N; Bishop, P; Arrand, John R; Rahman, A N; Carroll, K B; Woodcock, A A
Abstract:
A case is described of late pulmonary graft failure in a heart/lung transplant recipient. The major characteristics were alveolar fibrosis and a restrictive physiological deficit. Epstein-Barr virus was implicated as an aetiological agent using immunohistochemical analysis and by a response to treatment with ganciclovir.
Affiliation:
North West Lung Centre, Wythenshawe Hospital, Manchester.
Citation:
Epstein-Barr virus associated graft failure following heart/lung transplantation. 1996, 51 (11):1160-2; discussion 1164-5 Thorax
Journal:
Thorax
Issue Date:
Nov-1996
URI:
http://hdl.handle.net/10541/95806
DOI:
10.1136/thx.51.11.1160
PubMed ID:
8958903
Type:
Article
Language:
en
ISSN:
0040-6376
Appears in Collections:
All Paterson Institute for Cancer Research

Full metadata record

DC FieldValue Language
dc.contributor.authorEgan, J Jen
dc.contributor.authorStewart, J Pen
dc.contributor.authorHasleton, Philip Sen
dc.contributor.authorYonan, Nen
dc.contributor.authorBishop, Pen
dc.contributor.authorArrand, John Ren
dc.contributor.authorRahman, A Nen
dc.contributor.authorCarroll, K Ben
dc.contributor.authorWoodcock, A Aen
dc.date.accessioned2010-04-07T08:46:29Z-
dc.date.available2010-04-07T08:46:29Z-
dc.date.issued1996-11-
dc.identifier.citationEpstein-Barr virus associated graft failure following heart/lung transplantation. 1996, 51 (11):1160-2; discussion 1164-5 Thoraxen
dc.identifier.issn0040-6376-
dc.identifier.pmid8958903-
dc.identifier.doi10.1136/thx.51.11.1160-
dc.identifier.urihttp://hdl.handle.net/10541/95806-
dc.description.abstractA case is described of late pulmonary graft failure in a heart/lung transplant recipient. The major characteristics were alveolar fibrosis and a restrictive physiological deficit. Epstein-Barr virus was implicated as an aetiological agent using immunohistochemical analysis and by a response to treatment with ganciclovir.en
dc.language.isoenen
dc.subjectTumour Virus Infectionsen
dc.subject.meshAdult-
dc.subject.meshFemale-
dc.subject.meshGraft Rejection-
dc.subject.meshHeart-Lung Transplantation-
dc.subject.meshHerpesviridae Infections-
dc.subject.meshHerpesvirus 4, Human-
dc.subject.meshHumans-
dc.subject.meshPulmonary Fibrosis-
dc.subject.meshTumor Virus Infections-
dc.titleEpstein-Barr virus associated graft failure following heart/lung transplantation.en
dc.typeArticleen
dc.contributor.departmentNorth West Lung Centre, Wythenshawe Hospital, Manchester.en
dc.identifier.journalThoraxen

Related articles on PubMed

All Items in Christie are protected by copyright, with all rights reserved, unless otherwise indicated.